Alveolar MMP28 is associated with clinical outcomes and measures of lung injury in acute respiratory distress syndrome
Open Access
- 8 April 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-3
- https://doi.org/10.1186/s13054-020-02847-0
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K23 HL144916, P50 HL073996, R01 HL116514, K23 HL120896)
- Parker B. Francis Foundation (Fellowship)
This publication has 6 references indexed in Scilit:
- Alveolar Macrophage Transcriptional Programs Are Associated with Outcomes in Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2019
- Identification of MMP28 as a biomarker for the differential diagnosis of idiopathic pulmonary fibrosisPLOS ONE, 2018
- Reclassifying Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2018
- MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosisJournal of Leukocyte Biology, 2013
- A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury*Critical Care Medicine, 2011
- Epilysin (MMP-28) Restrains Early Macrophage Recruitment in Pseudomonas aeruginosa PneumoniaThe Journal of Immunology, 2009